Tue, March 17, 2020

Salveen Richter Initiated (ARWR) at Hold and Held Target at $45 on, Mar 17th, 2020

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. hold-and-held-target-at-45-on-mar-17th-2020.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Salveen Richter of Goldman Sachs, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold and Held Target at $45 on, Mar 17th, 2020.

Salveen has made no other calls on ARWR in the last 4 months.



There are 6 other peers that have a rating on ARWR. Out of the 6 peers that are also analyzing ARWR, 3 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alethia Young of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $55 on, Thursday, February 6th, 2020
  • Esther Rajavelu of "Oppenheimer" Initiated at Hold on, Friday, December 13th, 2019
  • Elemer Piros of "Cantor Fitzgerald" Maintained at Hold with Increased Target to $50 on, Tuesday, November 19th, 2019


These are the ratings of the 3 analyists that currently disagree with Salveen


  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $57 on, Friday, March 13th, 2020
  • Mani Foroohar of "SVB Leerink" Initiated at Sell and Held Target at $32 on, Tuesday, January 21st, 2020
  • Joel Beatty of "Baird" Upgraded from Hold to Buy and Increased Target to $70 on, Monday, November 25th, 2019